Yep, other companies have fallen into Sirrom's "clutches":
BUSINESS WIRE, March 13, 1998, Friday
HEADLINE: Management Change and New Addition to Clinicor Board
March 13, 1998--Clinicor, Inc. (OTC BB: CLCR), an innovative provider of
clinical research services to the pharmaceutical, biotechnology and medical
device industries, today announced that Thomas P. O'Donnell has resigned as
chief executive officer and Chairman of the Company. Mr. O'Donnell intends to
form a new venture that will provide merger and acquisition and other financial
consulting services to the healthcare industry. Robert S. Sammis, Clinicor's
President, has assumed the duties of chief executive officer.
Clinicor also announced that Craig Macnab, 42, President of Tandem
Capital, Inc. has joined the Board effective March 4, 1998. Tandem Capital
provides growth capital to small, rapidly growing micro-cap public companies.
In November 1997, Tandem Capital made a $ 5 million private equity investment
in Clinicor.
Mr. Sammis commented, "In the five years since Tom and I founded the
Company, Clinicor has emerged as a first-rate clinical research service
organization with growing recognition as a provider of unique, value-added CRO
services. The Company is very appreciative of Tom's efforts and
accomplishments." Sammis continued, "We are pleased to welcome Craig Macnab to our Board, and we expect to benefit from his wealth of capital markets experience."
Craig Macnab joined Tandem Capital as President in January 1997. Prior to
joining Tandem, Mr. Macnab served as General Partner of MacNiel Advisors, Inc.
(1993 to 1996), the general partner of three private funds that invest in small
public companies. Macnab was Partner of Nashville, Tennessee-based regional
broker J.C. Bradford & Co. (1987 to 1993), where he was jointly responsible
for the merger and acquisition department and a private mezzanine capital fund.
He began his investment banking career at Lazard Freres & Co. in 1981.
|
